Marex Group (MRX) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
30 Nov, 2025Management team and governance
Executive officers and directors are indemnified against liabilities incurred in their duties, subject to legal limitations and exclusions for fraud, willful default, or gross negligence.
Deeds of indemnity are in place for all executive officers and directors, and liability insurance coverage is provided and planned to be expanded.
The board includes a Chair, CEO, CFO, and several independent directors, with signatures from key officers and directors included in the filing.
Offering details and pricing
The registration statement covers the issuance of senior debt securities, with the aggregate principal amount unlimited and issuable in series.
Debt securities may be issued in various currencies, denominations, and forms, including global securities and master notes, with terms set in board resolutions and officer certificates.
Redemption, repayment, and conversion features are determined by pricing supplements for each series, and securities may be exchangeable or convertible under specified conditions.
The offering is structured to allow for continuous or delayed offerings, with provisions for post-effective amendments and updates as required by law.
Underwriters and syndicate
Citibank, N.A. is named as trustee, paying agent, and registrar for the senior debt securities.
Mayer Brown LLP and Mayer Brown International LLP provide legal opinions on the validity and legality of the notes under English and U.S. law.
Latest events from Marex Group
- Record profit growth, expanding margins, and strategic M&A drive robust, resilient performance.MRX
Piper Sandler Global Exchange and Fintech Conference3 Jun 2026 - All resolutions, including Bermuda redomiciliation, passed to streamline structure and support growth.MRX
EGM 20263 Jun 2026 - 2025 saw 27% revenue growth, 30% profit growth, and expanding margins from scalable, recurring earnings.MRX
Investor presentation18 May 2026 - Record Q1 2026 revenue and profit growth driven by strong segment performance and market volatility.MRX
Q1 20266 May 2026 - Record growth, margin expansion, and digital asset leadership drive resilient global scale.MRX
Investor Day 202627 Apr 2026 - Record FY 2025 profit and revenue growth, supported by scale, diversification, and strong risk controls.MRX
Corporate presentation24 Mar 2026 - Record revenue and profit growth in 2025, with strong segment performance and robust capital position.MRX
Q4 20253 Mar 2026 - Record H1 2024 results with 27% revenue growth, strong margins, and positive full-year outlook.MRX
H1 20242 Feb 2026 - Growth driven by public listing, M&A, and diversification, with strong risk management focus.MRX
Piper Sandler Global Exchange and Trading Conference 202431 Jan 2026 - Strong H1 growth, global expansion, and product innovation drive resilient, diversified performance.MRX
Barclays 22nd Annual Global Financial Services Conference21 Jan 2026